DNA integrity in diagnosis of premalignant lesions
- PMID: 33340077
- PMCID: PMC8254884
- DOI: 10.4317/medoral.24287
DNA integrity in diagnosis of premalignant lesions
Abstract
Background: Carcinogenesis is a dynamic process which traditional biopsying can not keep up with. Saliva as fluid in the vicinity of the tumor can offer better insights to this process. This study aimed to identify the accuracy of salivary DNA integrity index in differentiating between oral premalignant lesions and oral cancer.
Material and methods: This phase II diagnostic test accuracy study included 93 patients divided into three groups: 30 oral cancer patients, 33 patients with oral premalignant lesions divided into 21 oral lichen planus patients and 12 patients with leukoplakia and 30 normal individuals who acted as controls. Oral rinse was collected from all participants and they all underwent conventional visual and tactile examination, and patients with oral lesions had the diagnosis confirmed by histopathological examination of tissue biopsy. DNA integrity index was determined as the ratio between ALU247 and ALU115 measured by qPCR.
Results: There was no statistically significant difference regarding ALU115, ALU247 and DNA integrity index between the three study groups. The index was significantly higher in the oral cancer group than the oral lichen planus patients, while no significant difference was found between the oral cancer and the leukoplakia cases. The DNA integrity index sensitivity, specificity, positive and negative predictive values were 73%, 45%, 55% and 65% respectively.
Conclusions: Salivary DNA integrity index showed poor diagnostic abilities in differentiating between the oral cancer and premalignant lesions.
Conflict of interest statement
Conflicts of interest The authors declare no conflict of interest.
Figures
Similar articles
-
Application of a non-invasive oral brushing procedure based on bisulfite sequencing of a 13-gene panel to study high-risk OSCC patients.Cancer Biomark. 2020;28(4):499-510. doi: 10.3233/CBM-190422. Cancer Biomark. 2020. PMID: 32568174
-
Cytology of the oral cavity: a re-evaluation.Pathologica. 2009 Feb;101(1):6-8. Pathologica. 2009. PMID: 19771764
-
Salivary 8-hydroxy-2-deoxyguanosine, malondialdehyde, vitamin C, and vitamin E in oral pre-cancer and cancer: diagnostic value and free radical mechanism of action.Clin Oral Investig. 2016 Mar;20(2):315-9. doi: 10.1007/s00784-015-1506-4. Epub 2015 Jun 17. Clin Oral Investig. 2016. PMID: 26077895
-
Molecular genetics of premalignant oral lesions.Oral Dis. 2007 Mar;13(2):126-33. doi: 10.1111/j.1601-0825.2006.01349.x. Oral Dis. 2007. PMID: 17305612 Review.
-
Häufige Mundschleimhauterkrankungen.Praxis (Bern 1994). 2017 Jan;106(1):21-27. doi: 10.1024/1661-8157/a002571. Praxis (Bern 1994). 2017. PMID: 28055317 Review. German. No abstract available.
Cited by
-
Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer.J Oncol. 2022 May 31;2022:9538384. doi: 10.1155/2022/9538384. eCollection 2022. J Oncol. 2022. PMID: 35685424 Free PMC article.
-
Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.J Oral Pathol Med. 2022 May;51(5):429-435. doi: 10.1111/jop.13299. Epub 2022 Apr 26. J Oral Pathol Med. 2022. PMID: 35416334 Free PMC article.
-
Liquid Biopsy in Head and Neck Cancer: Its Present State and Future Role in Africa.Cells. 2023 Nov 20;12(22):2663. doi: 10.3390/cells12222663. Cells. 2023. PMID: 37998398 Free PMC article. Review.
-
Cell-Free DNA as a Prognostic Biomarker in Oral Carcinogenesis and Oral Squamous Cell Carcinoma: A Translational Perspective.Cancers (Basel). 2025 Jul 16;17(14):2366. doi: 10.3390/cancers17142366. Cancers (Basel). 2025. PMID: 40723249 Free PMC article. Review.
-
Saliva-based cell-free DNA and cell-free mitochondrial DNA in head and neck cancers have promising screening and early detection role.J Oral Pathol Med. 2023 Jan;52(1):29-36. doi: 10.1111/jop.13392. Epub 2022 Dec 13. J Oral Pathol Med. 2023. PMID: 36459078 Free PMC article.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. - PubMed
-
- Jin LJ, Lamster IB, Greenspan JS, Pitts NB, Scully C, Warnakulasuriya S. Global burden of oral diseases: emerging concepts, management and interplay with systemic health. Oral Dis. 2016;22:609–19. - PubMed
-
- Lingen MW, Abt E, Agrawal N, Chaturvedi AK, Cohen E, D'Souza G. Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American Dental Association. J Am Dent Assoc. 2017;48:712–27. - PubMed
-
- Raj AT, Kheur S, Gupta AA, Patil VR, Kharat A. The need for combination immunotherapy in oncology. Oral Oncol. 2019;91:123. - PubMed
-
- Dionne K, Warnakulasuriya S, Zain R, Cheong S. Potentially malignant disorders of the oral cavity: Current practice and future directions in the clinic and laboratory. Int J Cancer. 2015;136:503–15. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical